Kristen Fortney is the co-founder and CEO of BioAge Labs, a clinical-stage biotechnology company developing a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging. In this conversation with Stanford adjunct lecturer Toby Corey, Fortney discusses strategies for reducing risk along the path to developing world-changing therapies.--------------------Stanford eCorner content is produced by the Stanford Technology Ventures Program. At STVP, we empower aspiring entrepreneurs to become global citizens who create and scale responsible innovations.CONNECT WITH USTwitter: https://twitter.com/ECorner LinkedIn: https://www.linkedin.com/company/stanfordtechnologyventuresprogram/ Facebook: https://www.facebook.com/StanfordTechnologyVenturesProgram/ YouTube: https://www.youtube.com/user/ecorner LEARN MOREeCorner Website: https://ecorner.stanford.edu/STVP Website: https://stvp.stanford.edu/Support our mission of providing students and educators around the world with free access to Stanford University's network of entrepreneurial thought leaders: https://ecorner.stanford.edu/give.